focus -WSS

focus

author：entertainment 2025-09-05 15:43:29 - browse：28667

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

WSS

What Henrietta Lacks settlement says about racism in medicine

Microbiome research is starting to find links to chronic diseases

Microsoft strikes partnership with Duke Health to advance health AI

Humana, CVS hope to turn members into patients at clinics

Verily hires former Apple Health leader as chief scientific officer

Medical student insurance fails on mental health care coverage

leisure time

focus

entertainment

Cancer drug shortages should be causing more outrage

Why are Kaiser Permanente staff considering a strike?

What does generative AI mean for health care? We asked experts

For BCIs, commercial hurdles may be bigger than scientific ones

Tori Bowie and the unacceptable rates of Black maternal death

Experts study whether long Covid risk adds up with each reinfection

Supreme Court strikes down use of affirmative action

Gilgo Beach: Police identify another victim in serial killing investigation

Hepatitis C has a cure — but many Americans still lack access to it

Thermo Fisher plant for manufacturing gene therapies to expand

hotspot

How Vertex's cystic fibrosis drug is changing patients' lives

Senate HELP committee spars over health care workforce policies

What Congress can do to address the rural doctor shortage

OTC birth control: A brief history of over the counter pill design

Biden calls for immediate release of Niger's president amid apparent coup

The drug industry sees a key ally in the Senate prevail

knowledge

leisure time

knowledge

Wikipedia